<i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>

Marie Sylvianne Rabodoarivelo, Jordana Galizia, Deborah Recchia, Alessandro Stamilla, Michael Dal Molin, Eik Hoffmann, Cyril Gaudin, Maxime Eveque, Dominique Ndjogou, Rebeca Bailo, Albin A. M. Leding, Ulrika S. H. Simonsson, Olalla Sanz, Elena Jiménez, Robert H. Bates, Giulia Degiacomi, Ainhoa Lucía, Nicolas Willand, Alain Baulard, Jan Rybniker, Maria Rosalia Pasca, Santiago Ramón-García, Unknown

Open source

DOI
10.1128/aac.00260-26
Published
2026-08-05
Container
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00260-26,
  title = {<i>In vitro</i>
                    characterization of GSK2556286 in combination with bedaquiline and pretomanid against
                    <i>Mycobacterium tuberculosis</i>},
  author = {Marie Sylvianne Rabodoarivelo and Jordana Galizia and Deborah Recchia and Alessandro Stamilla and Michael Dal Molin and Eik Hoffmann and Cyril Gaudin and Maxime Eveque and Dominique Ndjogou and Rebeca Bailo and Albin A. M. Leding and Ulrika S. H. Simonsson and Olalla Sanz and Elena Jiménez and Robert H. Bates and Giulia Degiacomi and Ainhoa Lucía and Nicolas Willand and Alain Baulard and Jan Rybniker and Maria Rosalia Pasca and Santiago Ramón-García and Unknown},
  year = {2026},
  journal = {Antimicrobial Agents and Chemotherapy},
  doi = {10.1128/aac.00260-26},
  url = {https://doi.org/10.1128/aac.00260-26}
}

RIS

TY  - JOUR
TI  - <i>In vitro</i>
                    characterization of GSK2556286 in combination with bedaquiline and pretomanid against
                    <i>Mycobacterium tuberculosis</i>
AU  - Marie Sylvianne Rabodoarivelo
AU  - Jordana Galizia
AU  - Deborah Recchia
AU  - Alessandro Stamilla
AU  - Michael Dal Molin
AU  - Eik Hoffmann
AU  - Cyril Gaudin
AU  - Maxime Eveque
AU  - Dominique Ndjogou
AU  - Rebeca Bailo
AU  - Albin A. M. Leding
AU  - Ulrika S. H. Simonsson
AU  - Olalla Sanz
AU  - Elena Jiménez
AU  - Robert H. Bates
AU  - Giulia Degiacomi
AU  - Ainhoa Lucía
AU  - Nicolas Willand
AU  - Alain Baulard
AU  - Jan Rybniker
AU  - Maria Rosalia Pasca
AU  - Santiago Ramón-García
AU  - Unknown
PY  - 2026
JO  - Antimicrobial Agents and Chemotherapy
DO  - 10.1128/aac.00260-26
UR  - https://doi.org/10.1128/aac.00260-26
ER  - 

APA

Rabodoarivelo, M. S., Galizia, J., Recchia, D., Stamilla, A., Molin, M. D., Hoffmann, E., Gaudin, C., Eveque, M., Ndjogou, D., Bailo, R., Leding, A. A. M., Simonsson, U. S. H., Sanz, O., Jiménez, E., Bates, R. H., Degiacomi, G., Lucía, A., Willand, N., Baulard, A., Rybniker, J., Pasca, M. R., Ramón-García, S., & Unknown (2026). <i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00260-26

Source records